Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Royal Bank of Canada (RY) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Royal Bank of CanadaTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Royal Bank of Canada vs Health Care Select Sector SPDR Fund — how do they compare? Royal Bank of Canada trades at $210.37 (market cap $289.51B), while Health Care Select Sector SPDR Fund trades at $160.19. The key difference: Royal Bank of Canada pays a 2.42% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals.

RYXLV
Market Cap
$289.51B
Sector
Financials
52-Week High
$217.87$164.48
52-Week Low
$128.46$129.01
Dividend Yield
2.42%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Royal Bank of Canada

Royal Bank of Canada (RY) trades at $210.88, down 2.11% on the day, amid a bullish technical setup with support near $208 and resistance at $214. The company reported strong Q1 2026 earnings of $2.84 per share, beating estimates, and has a history of recent beats. Revenue grew to $66.53B in 2025, with a net income margin of 31.85% and a solid ROE of 17.17%. Analyst sentiment is mixed but leans positive, with a 43% buy rating.

RY's outlook is supported by consistent earnings performance and a robust dividend, recently increased to $1.76 per share. However, risks include elevated valuation multiples like a P/E of 19.42 and macroeconomic sensitivity. The stock offers stability through its banking diversification but faces headwinds from interest rate volatility and credit quality concerns.

Health Care Select Sector SPDR Fund

XLV trades at $159.25, down 1.14% with neutral technical signals overall. The healthcare ETF shows mixed momentum with bullish moving averages but neutral oscillators. Recent news highlights XLV's defensive characteristics amid market volatility, with State Street upgrading healthcare to positive for Q3 2026. The fund's diversified approach offers stability compared to more volatile biotech-focused alternatives.

XLV presents a defensive opportunity with lower costs and steady performance, though upside may be limited in the current cycle. Key risks include patent cliff concerns and sector rotation away from defensive plays if market sentiment improves. The ETF's broad healthcare exposure provides cushion against individual stock volatility while benefiting from pipeline innovations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Royal Bank of Canada

Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.

Read more on RY

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV